Announcement on Change in Accounting Policies
Filed with SSE · · 2 pages · Chinese
Summary by 6ix AI
The change is in accordance with new interpretations issued by the Ministry of Finance of the People's Republic of China. This adjustment will not significantly impact the company's financial status, operating results, or cash flow. The company assures that the change aligns with legal regulations and will not harm the interests of shareholders.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
On 6ix: 6ix.com/news/jiangsu-bioperfectus-technologies-co-ltdannouncement-on-change-in-accounting-policies
Jiangsu Bioperfectus Technologies Co. Ltd. on 6ix
Earlier from Jiangsu Bioperfectus Technologies
- Indicative Announcement on the Termination of the Acting-in-Concert Relationship among Relevant Shareholders and the Change of the Actual Controller
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Voluntary Disclosure of Changing Medical Device Registration Certificate
- Notice on Convening the 2025 Annual General Meeting
Later from Jiangsu Bioperfectus Technologies
- Indicative Announcement on Postponement of Election of New Board of Directors
- Indicative Announcement on Change of the Executive Partner of the Partnership and Change in Equity Interests of Shareholders
- Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- (688399)"Jiangsu Bioperfectus Technologies Co., Ltd."Announcement on Resolutions of the 18th Meeting of the 3rd Board of Directors
Follow Jiangsu Bioperfectus Technologies into a list and get an email when it puts out news.
Follow Jiangsu Bioperfectus Technologies